Creating Next Generation
Smart Cell Therapies
Outpace is pushing the boundaries of biology to create tailored cell therapy solutions through protein design and custom programming.
Our Approach
Outpace is combining the design of improved biological functions and cellular control modalities to harness the full complexity of cellular biology to tackle incurable disease. We create mechanism-driven solutions tailor-made to dramatically improve efficacy and safety.
Solve specific problems by reimagining proteins at the structural level, beyond traditional protein engineering
Program cell therapies to have the right response at the right time and place
Rapidly test hypotheses at scale
Solve specific problems by reimagining proteins at the structural level, beyond traditional protein engineering
The Right Solutions for
the Most Important Problems
We use our unique combination of protein design and cell engineering expertise to solve holy grail problems in cell and gene therapy. We use Rosetta, the most advanced protein design software in the world, to custom design new biological functions. Each solution adds new proteins to our physical platform with generalizable functions that we can repurpose to solve future problems.
Protein Design Platform
Physical Platform
Solutions
Design new biological functions
Outpace-owned proteins with
generalizable functions
Solutions to holy grail
problems in cell therapy
Ligand Redesign
Oligomerization and Orientation
Drug-induced Dimerization
Protein Actuator
Logic Gate
Our Platform
Outpace's technologies can modulate diverse biological functions using different control modalities, providing the opportunity to create the optimal solution. Our versatile platform can be applied across multiple problems in diverse areas of biology.
Pipeline
Strategic collaborations with world-leading biotechnology and pharmaceutical companies are the cornerstone of the Outpace Business model. In addition to collaboratively developing assets for our partners' portfolios, we are also developing an internal pipeline as the foundation for future development.
Team
Leadership
Scott Boyken, PhD
CSO
Marc Lajoie, PhD
CEO
Cellular
Control
Glenna Foight, PhD
Ty Crowl
Robin Kirkpatrick, PhD
Leah Tait
Howell Moffett, PhD
Andrew Ng, PhD
Cindy Yang
Custom Biological
Function
Tad Davenport. PhD
Bobby Langan, PhD
Lisa Song
Brian Weitzner, PhD
Syn Bio
Foundry
Emily Bringgold
Kieran Lewis
Aye Chen
Jen Running Deer
Brad Hammerson
Lesley Jones
Board of
Directors
Vasudev Bailey, PhD
Partner, Artis Ventures
Scott Boyken, PhD
CSO, Outpace Bio
Marc Lajoie, PhD
CEO, Outpace Bio
Investors
